Ad26.cov2-s/elasomeranLack of efficacy:2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1942卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32626-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[31] Ad26.COV2-S/AZD-1222/tozinameranSubacute thyroiditis: 3 case reports
Reactions Weekly, 2022, 1924 (1) : 21 - 21
[32] Ad26.cov2-s/elasomeranBranch retinal vein occlusion and acute macular neuroretinopathy: 2 case reports
Reactions Weekly, 2022, 1911 (1) : 17 - 17
[33] Ad26.cov2-s/elasomeranRecurrent generalised anhidrosis: case report
Reactions Weekly, 2023, 1957 (1) : 17 - 17
[34] Ad26.cov2-s/elasomeran/immune globulin/tozinameranGuillain-Barre syndrome and lack of efficacy: 10 case reports
Reactions Weekly, 2023, 1952 (1) : 26 - 26
[35] Ad26.cov2-s/tozinameranAcute limb ischaemia secondary to thrombotic thrombocytopenia: 3 case reports
Reactions Weekly, 2023, 1985 (1) : 22 - 22
[36] Ad26.COV2-S/tozinameranChronic spontaneous urticaria
Reactions Weekly, 2023, 1987 (1) : 16 - 16
[37] Ad26.COV2-S/elasomeran/tozinameranTransverse myelitis
Reactions Weekly, 2024, 2003 (1) : 26 - 26
[38] Ad26.COV2-S/Adalimumab/ElasomeranPapulopustular psoriasis
Reactions Weekly, 2024, 1999 (1) : 18 - 18
[39] Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTechLack of efficacy: case report
Reactions Weekly, 2021, 1866 (1) : 15 - 15
[40] Ad26.cov2-s/enoxaparin-sodium/tozinameranRelapsing remitting multiple sclerosis and thrombocytopenia: 2 case reports
Reactions Weekly, 2022, 1919 (1) : 20 - 20

← 1 2 3 4 5 →